Register to receive a free U.S. Soft Tissue Reinforcement and Regeneration Market report synopsis and brochure
AirXpanders, a California-based breast reconstruction device company, is being introduced to the Australian market with much enthusiasm. Their flagship tissue expander, the AeroForm®, is placed inside the patient during the mastectomy. Following the procedure, the patient uses a handheld wireless controller to inflate the device gradually with compressed CO2 gas through an internal valve. After several weeks, this results in a “stretched out pouch” in which permanent breast implants are placed. The AeroForm® boasts several advantages over traditional breast reconstruction technology. It is needle-free, it takes less time, it is less painful, and it requires a shorter recovery period.
“We believe that every woman deserves a comfortable, efficient breast reconstruction journey and the highest possible quality of life following a mastectomy, and that AeroForm is the best innovation in tissue expanders in decades. As a result, we consider AeroForm to be an attractive and compelling new alternative for this important patient group in a significant market,” said Scott Dodson, president and CEO of AirXpanders. “We are pleased to invite investors to share in AirXpanders’ exciting future as we scale up our manufacturing capacity and our sales and marketing infrastructure to undertake a full commercial launch of AeroForm in both Australia and the U.S.”
Late last year, the Australian Therapeutic Goods Administration (TGA) granted reimbursement approval for the AeroForm®. The Australian Institute of Health and Welfare reports that the number of breast cancer cases increases every year, and may exceed 17,000 in 2020.
AirXpanders Inc. is a medical device company focused on the area of breast cancer reconstruction. The AirXpander technology is a tissue expander that is used following a mastectomy to create a pocket under the patient’s chest muscle to allow for a permanent implant placement. Unlike standard saline expanders, the AirXpander uses continuous expansion over a much shorter period of time without all of the shortcomings of the existing technology (frequent office visits for expansion, excessive pain, long expansion duration, the use of needles). The mechanism employed is the use of CO2 which is patient activated in the comfort of their own home through a hand held controller.
For Further Information
More on the markets for breast reconstruction in the U.S. can be found in the 2015 edition report published by iData entitled U.S. Soft Tissue Reinforcement and Regeneration Market, covers the U.S. market segments for hernia repair, dural repair, vaginal slings, skin repair, sports medicine and tendon reinforcement, and dental soft tissue regeneration.
The iData series on the market for soft tissue reinforcement and regeneration devices covers the U.S., and 15 countries in Europe. Full reports also provide a comprehensive analysis including units sold, procedure numbers, market value, forecasts, as well as detailed competitive market shares and analysis of major players’ success strategies in each market and segment.
Register online or email us at [email protected] for a U.S. Soft Tissue Reinforcement and Regeneration Market report brochure and synopsis.
About Procedure Tracker
Procedure number data is available from iData’s Procedure Tracker service, which allows subscribers to define and analyze procedure data segmented by State, region, hospital, surgery centre, and physician. A customizable dashboard sorts procedure data for further analysis and research.
Explore our careers page for our current available job opportunities. This is your chance to join a fun and dynamic team in the medical market research industry. Send your resume to [email protected] with the job title in the subject line, and feel free to tell us a little about yourself. We look forward to hearing from you.